Decoy Therapeutics, Inc. (DCOY)
2.94
-0.04
(-1.34%)
USD |
NASDAQ |
Sep 03, 12:49
Decoy Therapeutics Research and Development Expense (TTM) : 2.230M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.230M |
| March 31, 2026 | 1.042M |
| December 31, 2025 | 0.3682M |
| September 30, 2025 | 0.4291M |
| June 30, 2025 | 0.5045M |
| March 31, 2025 | 0.6026M |
| December 31, 2024 | 0.77M |
| September 30, 2024 | 0.6546M |
| June 30, 2024 | 1.554M |
| March 31, 2024 | 3.691M |
| December 31, 2023 | 7.174M |
| September 30, 2023 | 11.80M |
| June 30, 2023 | 14.55M |
| March 31, 2023 | 15.12M |
| December 31, 2022 | 14.09M |
| September 30, 2022 | 11.42M |
| June 30, 2022 | 9.729M |
| December 31, 2021 | 8.548M |
| September 30, 2021 | 7.876M |
| June 30, 2021 | 7.664M |
| March 31, 2021 | 7.011M |
| December 31, 2020 | 6.914M |
| Date | Value |
|---|---|
| September 30, 2020 | 6.228M |
| June 30, 2020 | 5.566M |
| March 31, 2020 | 4.962M |
| December 31, 2019 | 4.019M |
| September 30, 2019 | 3.165M |
| June 30, 2019 | 2.378M |
| March 31, 2019 | 7.008M |
| December 31, 2018 | 10.99M |
| September 30, 2018 | 14.76M |
| June 30, 2018 | 19.15M |
| March 31, 2018 | 17.75M |
| December 31, 2017 | 16.99M |
| September 30, 2017 | 16.96M |
| June 30, 2017 | 17.89M |
| March 31, 2017 | 19.91M |
| December 31, 2016 | 20.38M |
| September 30, 2016 | 19.46M |
| June 30, 2016 | 17.24M |
| March 31, 2016 | 14.33M |
| December 31, 2015 | 12.75M |
| September 30, 2015 | 11.41M |
| June 30, 2015 | 8.869M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Palatin Technologies, Inc. | 12.33M |
| Unicycive Therapeutics, Inc. | 9.609M |
| Nuvectis Pharma, Inc. | 19.65M |
| ACADIA Pharmaceuticals, Inc. | 331.01M |
| Alnylam Pharmaceuticals, Inc. | 1.509B |